Pedram Razavi, Julia Ah-Reum An, Tatiana Erazo, Paul Schwartz, Loïc Ferrer, Olivier Gallinato, Léa Papillon, Thierry Colin, Marion Bossy, RosArio AndrE, Jessica Davies, Claudette Falato, Aisha Rashid, Sameet Sreenivasan, Adrien Decque, Amanda Remorino, David Dellamonica, Philippe Menu. "Prediction of real-world progression free survival (rwPFS) using a multimodal machine learning (ML) model for patients with HR+ HER2- metastatic breast cancer (mBC) undergoing first line (1L) treatment with cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) and endocrine therapy (ET).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e13088